124 related articles for article (PubMed ID: 32520497)
21. Esophageal metastasis from papillary thyroid cancer: diagnosis by 131I SPECT/CT.
Wisotzki C; Friese M; Ehresmann J; Derlin T
Clin Nucl Med; 2014 Jan; 39(1):e73-4. PubMed ID: 23455522
[TBL] [Abstract][Full Text] [Related]
22. Incidentally polycystic kidney disease identified by SPECT/CT with post-therapy radioiodine scintigraphy in a patient with differentiated thyroid carcinoma: A case report.
Mi YX; Sui X; Huang JM; Wei LG; Xie P
Medicine (Baltimore); 2017 Oct; 96(43):e8348. PubMed ID: 29069013
[TBL] [Abstract][Full Text] [Related]
23. I-131 Postablation SPECT/CT Predicts Relapse of Papillary Thyroid Carcinoma more Accurately than Whole Body Scan.
Malamitsi JV; Koutsikos JT; Giourgouli SI; Zachaki SF; Pipikos TA; Vlachou FJ; Prassopoulos VK
In Vivo; 2019; 33(6):2255-2263. PubMed ID: 31662565
[TBL] [Abstract][Full Text] [Related]
24. RAI thyroid bed uptake after total thyroidectomy: A novel SPECT-CT anatomic classification system.
Zeuren R; Biagini A; Grewal RK; Randolph GW; Kamani D; Sabra MM; Shaha AR; Tuttle RM
Laryngoscope; 2015 Oct; 125(10):2417-24. PubMed ID: 25891354
[TBL] [Abstract][Full Text] [Related]
25. Extrathyroidal Radioiodine Accumulation in a Fibroadenoma of the Breast.
Kim MH; Kim HS; Park SA
Clin Nucl Med; 2017 Feb; 42(2):e123-e125. PubMed ID: 27801741
[TBL] [Abstract][Full Text] [Related]
26. Clinical outcomes and prognostic factors of radioiodine ablation therapy for lymph node metastases from papillary thyroid carcinoma.
Wu X; Gu H; Gao Y; Li B; Fan R
Nucl Med Commun; 2018 Jan; 39(1):22-27. PubMed ID: 29135721
[TBL] [Abstract][Full Text] [Related]
27. Unusual Uptake of Radioiodine in a Subcutaneous Lipoma in a Patient With Differentiated Thyroid Cancer.
Shen G; Jing X; Zhang Y; Kuang A; Huang R
Clin Nucl Med; 2017 Jan; 42(1):e75-e76. PubMed ID: 27556799
[TBL] [Abstract][Full Text] [Related]
28. False-Positive Uptake of 131I From Basal Cell Papilloma in a Patient With Metastatic Papillary Thyroid Cancer.
Luo L; Wang J; Xia J; Zhang R; Yao X
Clin Nucl Med; 2021 Apr; 46(4):358-360. PubMed ID: 33492860
[TBL] [Abstract][Full Text] [Related]
29. Unusual 131Iodine uptake in a joint demonstrated by SPECT/CT in a patient with differentiated thyroid cancer.
Ciappuccini R; Aide N; Métayer L; Bardet S
Clin Nucl Med; 2015 Apr; 40(4):332-4. PubMed ID: 25674862
[TBL] [Abstract][Full Text] [Related]
30. Radioiodine Uptake of a Benign Peritoneal Cyst on 131-I Whole-body Scan in a Patient Treated for Papillary Thyroid Cancer.
Dabir M; Limberg J; Krieg A; Antke C; Sawicki LM
Nuklearmedizin; 2022 Apr; 61(2):130-131. PubMed ID: 34918331
[No Abstract] [Full Text] [Related]
31. I-131 SPECT/CT elucidates cryptic findings on planar whole-body scans and can reduce needless therapy with I-131 in post-thyroidectomy thyroid cancer patients.
Blum M; Tiu S; Chu M; Goel S; Friedman K
Thyroid; 2011 Nov; 21(11):1235-47. PubMed ID: 22007920
[TBL] [Abstract][Full Text] [Related]
32. An unusual false-positive uptake of radioiodine caused by pulmonary vasculature: The usefulness of SPECT/CT.
Yang F; Cao L; Zhang C
Hell J Nucl Med; 2020; 23(2):204-205. PubMed ID: 32716412
[TBL] [Abstract][Full Text] [Related]
33. Unusual uptake of radioiodine in a retroperitoneal bronchogenic cyst in a patient with thyroid carcinoma.
Jiang X; Zeng H; Gong J; Huang R
Clin Nucl Med; 2015 May; 40(5):435-6. PubMed ID: 25546201
[TBL] [Abstract][Full Text] [Related]
34. Low-dose radioiodine therapy for patients with intermediate- to high-risk differentiated thyroid cancer.
Abe K; Ishizaki U; Ono T; Horiuchi K; Kanaya K; Sakai S; Okamoto T
Ann Nucl Med; 2020 Feb; 34(2):144-151. PubMed ID: 31834567
[TBL] [Abstract][Full Text] [Related]
35. Accumulation of 131Iodine in the nasolacrimal sac/duct after radioiodine therapy for papillary thyroid cancer.
Usmani S; Jain A; Al-Riyami K; Abubakar S
J Pak Med Assoc; 2023 Mar; 73(3):713-714. PubMed ID: 36932793
[TBL] [Abstract][Full Text] [Related]
36. Radioiodine Retention Within Dilated Common Biliary Duct Mimicking Metastatic Thyroid Cancer Diagnosed by the Combination of SPECT/CT and MRI.
Dai H; Huang R
Clin Nucl Med; 2020 Oct; 45(10):787-788. PubMed ID: 32433174
[TBL] [Abstract][Full Text] [Related]
37. The effect of posttherapy 131I SPECT/CT on risk classification and management of patients with differentiated thyroid cancer.
Grewal RK; Tuttle RM; Fox J; Borkar S; Chou JF; Gonen M; Strauss HW; Larson SM; Schöder H
J Nucl Med; 2010 Sep; 51(9):1361-7. PubMed ID: 20720058
[TBL] [Abstract][Full Text] [Related]
38. Pulmonary aspergilloma mimicking metastasis from papillary thyroid cancer.
Ahn BC; Lee SW; Lee J; Kim C
Thyroid; 2011 May; 21(5):555-8. PubMed ID: 21449768
[TBL] [Abstract][Full Text] [Related]
39. Incidental 131I Activity in the Deltoid Region on Posttherapy Radioiodine Scan.
Strober MD; Callahan BR
Clin Nucl Med; 2017 Nov; 42(11):899-900. PubMed ID: 28902736
[TBL] [Abstract][Full Text] [Related]
40. Enthesopathy and tendinopathy in gout: computed tomographic assessment.
Gerster JC; Landry M; Rappoport G; Rivier G; Duvoisin B; Schnyder P
Ann Rheum Dis; 1996 Dec; 55(12):921-3. PubMed ID: 9014587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
